Zenas BioPharma, Inc. Quarterly Operating Lease, Liability in USD from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Zenas BioPharma, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2023 to Q2 2025.
  • Zenas BioPharma, Inc. Operating Lease, Liability for the quarter ending June 30, 2025 was $1.01M.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $1.01M Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $1.23M Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $1M +$190K +23.4% Dec 31, 2024 10-K 2025-03-11
Q3 2024 $384M Sep 30, 2024 10-Q 2024-11-12
Q4 2023 $813K Dec 31, 2023 10-K 2025-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.